Published in Cancer on June 15, 1997
The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer (2012) 10.90
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res (2009) 2.62
NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol (2013) 2.39
The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon. Hum Gene Ther (2009) 2.14
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron (2010) 1.96
Polarized immune responses differentially regulate cancer development. Immunol Rev (2008) 1.95
Thunder and lightning: immunotherapy and oncolytic viruses collide. Mol Ther (2011) 1.87
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med (2012) 1.86
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology (2012) 1.78
Chemokines in health and disease. Exp Cell Res (2011) 1.69
Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) (2013) 1.33
Natural killer cells in human cancer: from biological functions to clinical applications. J Biomed Biotechnol (2011) 1.28
Recognition of tumors by the innate immune system and natural killer cells. Adv Immunol (2014) 1.27
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer (2010) 1.16
NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies. Oncoimmunology (2012) 1.15
Oncolytic viruses as anticancer vaccines. Front Oncol (2014) 1.13
Immunology and immunotherapy of neuroblastoma. Semin Cancer Biol (2011) 1.08
Densely granulated murine NK cells eradicate large solid tumors. Cancer Res (2012) 1.04
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med (2013) 1.03
Modulation of immunity by antiangiogenic molecules in cancer. Clin Dev Immunol (2012) 1.01
Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity. Front Immunol (2014) 1.00
Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival. Br J Cancer (2002) 1.00
Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol (2014) 1.00
Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol (2011) 0.99
NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors. PLoS Pathog (2010) 0.98
NK cells: key to success of DC-based cancer vaccines? Oncologist (2012) 0.98
High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One (2013) 0.97
The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunol Res (2015) 0.96
Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol (2015) 0.94
Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells. J Cancer (2011) 0.94
Beneficial and Detrimental Roles of NLRs in Carcinogenesis. Front Immunol (2013) 0.94
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy. Cancer Discov (2014) 0.93
Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. Cancer Immunol Res (2014) 0.92
Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed (2015) 0.90
Clinical evaluation of systemic and local immune responses in cancer: time for integration. Cancer Immunol Immunother (2013) 0.89
Immune signatures predict prognosis in localized cancer. Cancer Invest (2010) 0.88
Shaping of NK cell responses by the tumor microenvironment. Cancer Microenviron (2012) 0.87
Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas. Mol Cancer (2006) 0.86
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. Br J Cancer (2013) 0.85
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Adv Virol (2011) 0.85
NK cell phenotypic modulation in lung cancer environment. PLoS One (2014) 0.85
Natural killer cells as helper cells in dendritic cell cancer vaccines. Front Immunol (2015) 0.84
Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. PLoS One (2011) 0.84
Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells. Front Immunol (2013) 0.84
Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival. Clin Exp Immunol (2011) 0.84
NK cells in the tumor microenvironment. Crit Rev Oncog (2014) 0.84
Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor. Diagn Pathol (2012) 0.84
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol (2011) 0.83
Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors. Clin Cancer Res (2015) 0.82
Dendritic cell defects in the colorectal cancer. Hum Vaccin Immunother (2014) 0.82
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy. J Immunol Res (2015) 0.81
Immunotherapy and immunoescape in colorectal cancer. World J Gastroenterol (2007) 0.81
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy. Br J Cancer (2014) 0.81
Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest. Biochem Pharmacol (2012) 0.81
Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma. Oncolytic Virother (2013) 0.80
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. PLoS One (2016) 0.80
Th inducing POZ-Kruppel Factor (ThPOK) is a key regulator of the immune response since the early steps of colorectal carcinogenesis. PLoS One (2013) 0.80
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. Transl Res (2015) 0.80
Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol (2015) 0.80
Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis. Oncoimmunology (2015) 0.78
Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res (2015) 0.78
Influence of immunotherapy with autologous dendritic cells on innate and adaptive immune response in cancer. Clin Med Insights Oncol (2013) 0.78
Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control. J Immunol (2013) 0.78
Autologous immune enhancement therapy: A case report of a stage IV colonic cancer. Oncol Lett (2013) 0.77
Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system. Int J Mol Sci (2014) 0.77
Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway. PLoS One (2016) 0.77
A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6. Cancer Sci (2016) 0.77
NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma. Front Med (Lausanne) (2015) 0.76
Tissue detection of natural killer cells in colorectal adenocarcinoma. BMC Gastroenterol (2004) 0.76
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila) (2014) 0.76
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas. BMC Clin Pathol (2012) 0.76
Whole Body Melanoma Transcriptome Response in Medaka. PLoS One (2015) 0.75
Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage. J Transl Med (2016) 0.75
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid. Oncoimmunology (2017) 0.75
Diet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer Incidence. J Nutr Metab (2017) 0.75
Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma. Front Immunol (2017) 0.75
Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells. Clin Immunol (2016) 0.75
Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al. J Immunother Cancer (2016) 0.75
Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study. J Oral Maxillofac Pathol (2016) 0.75
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function. Oncotarget (2016) 0.75
The dual role of complement in cancer and its implication in anti-tumor therapy. Ann Transl Med (2016) 0.75
Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine (Baltimore) (2016) 0.75
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy. Exp Mol Med (2017) 0.75
The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment. PLoS One (2016) 0.75
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. ScientificWorldJournal (2013) 0.75
Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model. Acta Biochim Biophys Sin (Shanghai) (2016) 0.75
The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunology (2015) 0.75
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer. Front Immunol (2017) 0.75
NK cell heparanase controls tumor invasion and immune surveillance. J Clin Invest (2017) 0.75
Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis. Oncoimmunology (2017) 0.75
A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer. Oncol Lett (2017) 0.75
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. J Immunother Cancer (2017) 0.75
[Clinical, pathological and molecular prognostic factors in colorectal carcinomas]. Pathologe (2003) 0.75
Natural killer cells and alterations in collagen density: signs of periradicular herpesvirus infection? Clin Oral Investig (2007) 0.75
Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer. J Cancer (2017) 0.75
NK Cell Exhaustion. Front Immunol (2017) 0.75
Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers. Front Immunol (2017) 0.75
Developing protein documentaries and other multimedia presentations for molecular biology. Pac Symp Biocomput (1999) 7.33
Tumors secreting human TNF/cachectin induce cachexia in mice. Cell (1987) 4.19
Impaired leucocyte functions in diabetic patients. Diabet Med (1997) 3.33
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab (2001) 3.31
Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med (1995) 2.58
Retracted Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J Biol Chem (2001) 2.31
Endoscopic diagnosis and treatment of an esophageal bezoar resulting from bulk laxative ingestion. Endoscopy (1994) 2.14
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest (1999) 2.08
Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect (2006) 2.06
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol (1993) 2.05
Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea. N Engl J Med (1986) 1.94
Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol (2003) 1.89
Regional diastolic function in ischaemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J (1999) 1.76
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res (2001) 1.69
Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60
Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab (2000) 1.56
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): diagnosis with fine-needle aspiration in a case with nodal and nasal involvement. Diagn Cytopathol (1995) 1.55
Effects of DksA and ClpP protease on sigma S production and virulence in Salmonella typhimurium. Mol Microbiol (1999) 1.55
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine (1995) 1.53
[The Doppler color detection of internal mammary artery anastomoses and a functional assessment of their patency]. Rev Esp Cardiol (1999) 1.48
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial. Ultrasound Obstet Gynecol (2012) 1.42
Open thoracotomy procedural competency: validity study of teaching and assessment modalities. Ann Emerg Med (1996) 1.41
A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig (2004) 1.40
[Transesophageal echocardiography in mitral prosthesis dysfunction: usefulness and limitations in the evaluation of mitral insufficiency]. Rev Esp Cardiol (1993) 1.40
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group. Ann Oncol (1994) 1.39
Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1,2 dimethyl-hydrazine (DMH). Rev Esp Enferm Dig (2005) 1.39
[Endoscopic management of postoperative biliary fistulas]. Rev Gastroenterol Mex (1992) 1.38
Echocardiographic features of left atrial dissection. Eur J Echocardiogr (2000) 1.38
The defensive role of nonspecific lipid-transfer proteins in plants. Trends Microbiol (1995) 1.34
Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry (2000) 1.33
Cerebral maturation in premature infants: quantitative assessment using MR imaging. AJNR Am J Neuroradiol (2001) 1.30
Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol Biochem Behav (2000) 1.30
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. Int J Obes (Lond) (2010) 1.28
Focus of Rift Valley fever virus transmission in southern Mauritania. Lancet (1987) 1.27
Biotype and macromolecular profiles of cytotoxin-producing strains of Helicobacter pylori from antral gastric mucosa. FEMS Microbiol Lett (1991) 1.27
Neurocytoma of spinal cord. Acta Neuropathol (1994) 1.25
Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA. Mol Cell Biol (1993) 1.24
Ribosomal RNA gene restriction patterns of Helicobacter pylori: analysis and appraisal of Hae III digests as a molecular typing system. Epidemiol Infect (1992) 1.23
Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst (1988) 1.23
Use of a specific immunogenic region on the Cowdria ruminantium MAP1 protein in a serological assay. J Clin Microbiol (1995) 1.23
Chagas disease in a recipient of cord blood transplantation. Bone Marrow Transplant (2007) 1.23
Oculomotor movements and football's Law 11. Lancet (1998) 1.21
Snakin-1, a peptide from potato that is active against plant pathogens. Mol Plant Microbe Interact (1999) 1.20
Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis (1996) 1.19
Inducible acid tolerance mechanisms in enteric bacteria. Novartis Found Symp (1999) 1.18
Effects of lipid composition on membrane permeabilization by sticholysin I and II, two cytolysins of the sea anemone Stichodactyla helianthus. Biophys J (2001) 1.18
Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol (1985) (1985) 1.18
Novel defensin subfamily from spinach (Spinacia oleracea). FEBS Lett (1998) 1.17
Magnetic resonance and cranial ultrasound characteristics of periventricular white matter abnormalities in newborn infants. Clin Radiol (2001) 1.16
Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J Exp Med (1988) 1.16
Tick-borne rickettiosis in Guadeloupe, the French West Indies: isolation of Rickettsia africae from Amblyomma variegatum ticks and serosurvey in humans, cattle, and goats. Am J Trop Med Hyg (1999) 1.16
Acute nicotine poisoning associated with a traditional remedy for eczema. Arch Dis Child (2001) 1.15
Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int J Obes Relat Metab Disord (2003) 1.15
Frequency of left ventricular free-wall rupture in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol (2000) 1.14
Magnetic resonance imaging of the infant brain: anatomical characteristics and clinical significance of punctate lesions. Arch Dis Child Fetal Neonatal Ed (2002) 1.14
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer (2000) 1.11
Biotype and molecular fingerprints of metronidazole-resistant strains of Helicobacter pylori from antral gastric mucosa. J Med Microbiol (1993) 1.11
Nuclear magnetic resonance studies of sodium ions in isolated frog muscle and liver. Biophys J (1969) 1.10
Relation between delay and survival in 596 patients with breast cancer. Oncology (1989) 1.10
Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmaniasis patients from the Dominican Republic. J Immunol (1984) 1.09
Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry (2013) 1.08
A primer-introduced restriction analysis-polymerase chain reaction method to detect knockdown resistance mutations in Anopheles gambiae. J Med Entomol (2008) 1.06
Comment on letter to the editor from S-O Hansson: 'homoeopathy and consumers right to know'. J Intern Med (2013) 1.06
Quantitative comparison of intrabrain diffusion in adults and preterm and term neonates and infants. AJR Am J Roentgenol (2000) 1.05
Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett (1999) 1.03
Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin. Proc Natl Acad Sci U S A (1993) 1.03
Trends in emergent inguinal hernia surgery in Olmsted County, MN: a population-based study. Hernia (2012) 1.02
Thyroid hormone and uncoupling proteins. FEBS Lett (2003) 1.02
Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice. J Immunol (1976) 1.01
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene (2012) 1.01
Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor. Proc Natl Acad Sci U S A (1987) 1.01
Purification and antipathogenic activity of lipid transfer proteins (LTPs) from the leaves of Arabidopsis and spinach. FEBS Lett (1993) 1.01
Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. Am J Cardiol (2000) 1.01
Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. Vector Borne Zoonotic Dis (2008) 1.00
Turnover of inositol phospholipids in cultured murine keratinocytes: possible involvement of inositol triphosphate in cellular differentiation. J Invest Dermatol (1988) 1.00
Image retake analysis in digital radiography using DICOM header information. J Digit Imaging (2008) 1.00
Realising the European Network of Biodosimetry (RENEB). Radiat Prot Dosimetry (2012) 0.99
Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett (2001) 0.99
Defining the transcriptomic and proteomic profiles of rat ageing skeletal muscle by the use of a cDNA array, 2D- and Blue native-PAGE approach. J Proteomics (2009) 0.99
Tuberculosis among urban health care workers: a study using restriction fragment length polymorphism typing. Clin Infect Dis (1995) 0.99
Pathogenetic mechanisms in immune polioencephalomyelitis: quantitative evaluation of protective and pathogenic effects of lymphoid cells. J Immunol (1976) 0.98
Effect of 3,3'-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity. Mol Cell Endocrinol (1992) 0.98
3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement. Am J Physiol Endocrinol Metab (2008) 0.97
Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases. BJOG (2000) 0.96
Action of thyroid hormones at the cellular level: the mitochondrial target. FEBS Lett (1999) 0.96
The sero-diagnosis of heartwater: a comparison of five tests. Rev Elev Med Vet Pays Trop (1993) 0.96
Validation and comparison of three enzyme-linked immunosorbent assays for the detection of antibodies to Cowdria ruminantium infection. Ann N Y Acad Sci (1998) 0.95
Trocar site hernia after laparoscopic ventral hernia repair. Surg Endosc (2006) 0.95
Infestation of rural houses by Triatoma infestans in the region of Los Llanos (La Rioja, Argentina). Mem Inst Oswaldo Cruz (2007) 0.94
Early dropouts from psychotherapy. J Nerv Ment Dis (1991) 0.94
16S rrn gene copy number in Helicobacter pylori and its application to molecular typing. J Appl Bacteriol (1992) 0.94
A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc Natl Acad Sci U S A (1992) 0.94
Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives. Infect Immun (1984) 0.94
Novel regulatory actions of 1 alpha,25-dihydroxyvitamin D3 on the metabolism of polyphosphoinositides in murine epidermal keratinocytes. J Cell Physiol (1987) 0.94
Portable spectral Doppler echocardiographic device: overcoming limitations. Heart (2003) 0.93
3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. J Biol Regul Homeost Agents (2012) 0.93
Expression of endogenous retroviruses is negatively regulated by the pluripotency marker Rex1/Zfp42. Nucleic Acids Res (2012) 0.93
Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer. Int J Cancer (1999) 0.93